Resolution of severe anaemia and hypotension secondary to rectal ulcers in a renal transplant patient after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)

被引：0

作者：

Ortega F. ^{[1
,2
]}

Baltar J. ^{[1
]}

机构：

[1] Hospital Universitario Central de Asturias, Oviedo, Asturias

[2] Hospital Universitario Central de Asturias, Health Outcomes Research Unit, Nephrology Service, Oviedo, Asturias

来源：

Drugs | 2006年 / 66卷 / Suppl 2期

关键词：

Mycophenolate Mofetil; Rectal Bleeding; Renal Transplant Patient; Basiliximab; Cyclosporine Microemulsion;

D O I：

10.2165/00003495-200666002-00007

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

页码：23 / 24

页数：1

共 50 条

[1] Resolution of severe anaemia and hypotension secondary to rectal ulcers in a renal transplant patient after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
Ortega, Francisco
Baltar, Jose
[J]. DRUGS, 2006, 66 : 23 - 24
[2] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) resolves gastrointestinal disorders in a patient with severe idiopathic aplastic anaemia
Rohrlich, Pierre-Sinion
Deconinck, Eric
Cahn, Jean-Yves
Plouvier, Emmanuel
[J]. DRUGS, 2006, 66 : 33 - 35
[3] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) resolves gastrointestinal disorders in a patient with severe idiopathic aplastic anaemia
Rohrlich P.-S.
Deconinck E.
Cahn J.-Y.
Plouvier E.
[J]. Drugs, 2006, 66 (Suppl 2) : 33 - 35
[4] Complete resolution of severe diarrhoea after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient at high immunological risk
Breidenbach, Thomas
Spangenberg, Marcus
Nagel, Eckhard
[J]. DRUGS, 2006, 66 : 25 - 27
[5] Complete Resolution of Severe Diarrhoea after Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®) in a Patient at High Immunological Risk
Thomas Breidenbach
Marcus Spangenberg
Eckhard Nagel
[J]. Drugs, 2006, 66 (Suppl 2) : 25 - 27
[6] Resolution of severe diarrhoea and return to work in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
Lord H.
[J]. Drugs, 2006, 66 (Suppl 2) : 11 - 13
[7] Resolution of severe diarrhoea and return to work in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
Lord, Helene
[J]. DRUGS, 2006, 66 : 11 - 13
[8] Resolution of gastrointestinal side effects in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
Tuncer, Murat
[J]. DRUGS, 2006, 66 : 9 - 10
[9] Resolution of gastrointestinal side effects in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
Tuncer M.
[J]. Drugs, 2006, 66 (Suppl 2) : 9 - 10
[10] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient with graft-versus-host disease
Kuhnowski F.
Terriou L.
Magro L.
Jouet J.-P.
Yakoub-Agha I.
[J]. Drugs, 2006, 66 (Suppl 2) : 29 - 31

← 1 2 3 4 5 →